drug-discovery-ab878726·1 events·first seen Aliases: drug discovery
OpenAI has announced GPT-Rosalind, a frontier reasoning model specifically designed for life sciences applications including drug discovery, genomics analysis, protein reasoning, and scientific research workflows. The model represents a domain-specialized deployment of OpenAI's reasoning capabilities targeted at biomedical research. This is a tier-1 lab release with a focused vertical application rather than a general-purpose model launch.